The Inflammatory Response in Psoriasis: a Comprehensive Review (Q38792930)

6 September 2017

title

The Inflammatory Response in Psoriasis: a Comprehensive Review (English)

1 reference

6 September 2017

0 references

Yaxiong Deng

1

1 reference

6 September 2017

Christopher Chang

series ordinal

2

1 reference

6 September 2017

Qianjin Lu

series ordinal

3

1 reference

6 September 2017

language of work or name

1 reference

30 March 2016

1 reference

Clinical Reviews in Allergy & Immunology

6 September 2017

published in

1 reference

6 September 2017

volume

50

1 reference

6 September 2017

issue

3

1 reference

6 September 2017

page(s)

377-389

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-016-8535-x

6 September 2017

exact match

0 references

cites work

The genetics of human autoimmune disease: A perspective on progress in the field and future directions

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Inflammasomes and human autoimmunity: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Autoimmunity: from black water fever to regulatory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Thymic B cells promote thymus-derived regulatory T cell development and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

21 January 2018

Genetics of psoriasis.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Peptidoglycan recognition proteins (PGRPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

New insights of T cells in the pathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Peptidoglycan: a major aetiological factor for psoriasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Diagnosis and classification of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Novel epigenetic changes unveiled by monozygotic twins discordant for smoking habits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Estimation of effect size distribution from genome-wide association studies and implications for future discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Polymorphisms of the IL12B and IL23R genes are associated with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Molecular dissection of psoriasis: integrating genetics and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The complexity of NF-κB signaling in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

CARD14 expression in dermal endothelial cells in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Genetic and epigenetic basis of psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The characteristics of genome-wide DNA methylation in naïve CD4+ T cells of patients with psoriasis or atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Emerging role of long noncoding RNAs in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Suppressors of cytokine signaling and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

MicroRNAs and potential target interactions in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic ker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

NF-κB: an essential transcription factor in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

TNF inhibitors directly target Th17 cells via attenuation of autonomous TNF/TNFR2 signalling in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Cost effectiveness of biologic therapies for plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

New biologics for psoriasis and psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Interleukin-17 and innate immunity in infections and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The interleukin-15 system suppresses T cell-mediated autoimmunity by regulating negative selection and nTH17 cell homeostasis in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-17C regulates the innate immune function of epithelial cells in an autocrine manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Differentiation and function of Th17 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Effects of Malassezia yeasts on serum Th1 and Th2 cytokines in patients with guttate psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Critical regulation of early Th17 cell differentiation by interleukin-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

A T cell extrinsic mechanism by which IL-2 dampens Th17 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Innate immunity and antimicrobial defense systems in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Cutting edge: A critical functional role for IL-23 in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Phenotypical and functional specialization of FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Advances on regulatory T cells from the 15th International Congress of Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Humoral autoimmunity: a failure of regulatory T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Dermal γδ T cells--a new player in the pathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

21 January 2018

Immunology of psoriasis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Disease mimicry--a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Regulatory dendritic cells in autoimmunity: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Resident and "inflammatory" dendritic cells in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Human dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

21 January 2018

NK cells and psoriasis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

A subpopulation of CD163-positive macrophages is classically activated in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

NOS2 and CCL27: clinical implications for psoriasis and eczema diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Treatment of Eczema: Corticosteroids and Beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Psoriasis and its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Immunomodulatory drugs for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Novel mechanisms of action of the biologicals in rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

The IL-23 axis in Salmonella gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Secukinumab (AIN457) for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Polymyalgia rheumatica--diagnosis and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Unmet needs in autoimmunity and potential new tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

GITR+ regulatory T cells in the treatment of autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8535-X

Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population

21 January 2018

1 reference

12 December 2020

Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris

1 reference

12 December 2020

Golimumab, the newest TNF-α blocker, comes of age.

1 reference

12 December 2020

Serum interferon-gamma is a psoriasis severity and prognostic marker

1 reference

12 December 2020

Oral apremilast in the treatment of active psoriatic arthritis: results of a multicenter, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells

1 reference

12 December 2020

Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis

1 reference

12 December 2020

The Role of Streptococcal Infection in the Initiation of Guttate Psoriasis

1 reference

12 December 2020

Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.

1 reference

12 December 2020

A systematic review of treatments for severe psoriasis

1 reference

12 December 2020

T cells involved in psoriasis vulgaris belong to the Th1 subset

1 reference

12 December 2020

Epigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris

1 reference

12 December 2020

The natural history of psoriasis in 5,600 patients.

1 reference

12 December 2020

Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21

1 reference

12 December 2020

PSORS1: linking genetics and immunology

1 reference

12 December 2020

Genetics of psoriasis and psoriatic arthritis: update and future direction.

1 reference

12 December 2020

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

1 reference

12 December 2020

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

12 December 2020

Involvement of IL-17F via the induction of IL-6 in psoriasis

1 reference

12 December 2020

IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family

1 reference

12 December 2020

Analysis of Th1/Th2 response pattern for erythrodermic psoriasis

1 reference

12 December 2020

Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study

1 reference

12 December 2020

Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine

1 reference

12 December 2020

Perforin expression is upregulated in the epidermis of psoriatic lesions

1 reference

12 December 2020

[The role of perforin mediated cell cytotoxicity in psoriasis]

1 reference

12 December 2020

Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris

1 reference

12 December 2020

Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis

1 reference

12 December 2020

1 reference

12 December 2020

Safety and efficacy of the tumor necrosis factor antagonists

1 reference

12 December 2020

Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis

1 reference

12 December 2020

Hiding under the skin: Interleukin-17-producing γδ T cells go under the skin?

1 reference

12 December 2020

1 reference

12 December 2020

Etanercept as monotherapy in patients with psoriasis

1 reference

12 December 2020

CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation

1 reference

12 December 2020

Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets

1 reference

12 December 2020

Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis

1 reference

12 December 2020

Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis

1 reference

12 December 2020

Psoriasis: the plot thickens....

1 reference

12 December 2020

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

12 December 2020

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis

1 reference

12 December 2020

Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder

1 reference

12 December 2020

Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis

1 reference

12 December 2020

10.1007/S12016-016-8535-X

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1026939627

0 references

Fatcat ID

release_34nifoz3rvctjpj5kbnahsfdme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/34nifoz3rvctjpj5kbnahsfdme

24 November 2022

mapped directly with Wikidata item

1 reference